-
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
25 Apr 2024 01:52 GMT
… 800-332-1088).
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is … statements are based on Jazz Pharmaceuticals' current plans, objectives, … risks and uncertainties affecting Jazz Pharmaceuticals and its development programs, including …
-
Incyte adds to pipeline with acquisition of Escient Pharmaceuticals
24 Apr 2024 22:42 GMT
… Healio
Incyte is acquiring Escient Pharmaceuticals for $750 million.
The deal … of diseases.
Incyte and Escient Pharmaceuticals have entered a definitive agreement … and EP547.
Incyte and Escient Pharmaceuticals have entered a definitive agreement …
-
Portland biotech Sparrow Pharmaceuticals raises $10M to further clinical trials
24 Apr 2024 22:08 GMT
-
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024
24 Apr 2024 20:17 GMT
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced … accessing the call.
About Acadia Pharmaceuticals
Acadia is advancing breakthroughs in …
-
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
24 Apr 2024 20:05 GMT
… , 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a … live call. About Supernus Pharmaceuticals, Inc. Supernus Pharmaceuticals is a biopharmaceutical company … Vice President and CFO
Supernus Pharmaceuticals, Inc.
(301) 838-2591 …
-
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
24 Apr 2024 20:05 GMT
… , 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) … containing chemotherapy. About Corbus
Corbus Pharmaceuticals Holdings, Inc. is a precision … Moran
Chief Financial Officer
Corbus Pharmaceuticals
smoran@corbuspharma.com Bruce …
-
Arrowhead Pharmaceuticals to Webcast Fiscal 2024 Second Quarter Results
24 Apr 2024 20:16 GMT
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today … the call.
About Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals develops medicines that treat intractable … events or circumstances.
Source: Arrowhead Pharmaceuticals, Inc.
View source version on …
-
Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
24 Apr 2024 20:01 GMT
… , 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a … following the presentations. About Rhythm Pharmaceuticals
Rhythm is a commercial-stage … Relations and Corporate Communications
Rhythm Pharmaceuticals, Inc.
857-264-4280
dconnolly …
-
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
24 Apr 2024 19:17 GMT
… behalf of investors of Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company …
-
BioCryst Pharmaceuticals gets grant for inhibitors of the complement system for disease treatment
24 Apr 2024 16:01 GMT
… ’s company profile on BioCryst Pharmaceuticals, Cancer treatment biomarkers was a … area identified from patents. BioCryst Pharmaceuticals's grant share as … ’s detailed insights on BioCryst Pharmaceuticals, buy the report here.
From …